Erbasan E, Aliciaslan M, Erendor F, Dandin O, et al. Lantidra (donislecel) in type 1 diabetes: An in-depth analysis of pharmacology, clinical effectiveness, safety, and the therapeutic role of the first FDA-approved allogeneic islet cell therapy. Diabet Med 2025 Nov 11:e70168. doi: 10.1111/dme.70168.
PMID: 41219164